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1. Introduction 
Human or bovme commercial albumms are 
frequently used m experiments mvolvlng lipoprotein 
metabohsm, for mamtaimng oncottc pressure m organ 
perfusron systems m the study of synthesis and metab- 
ohsm ofhpoprotems [ l-31 and as acceptors for fatty 
acids m studies of trrglycende catabolism by hpo- 
protein hpase (LPL, EC 3 .l .1.34) [3--51 The albumin 
preparatrons are supposed to be pure and devoid of 
apohpoprotems, and besides then ability to bmd 
fatty acids and lysolecithin, to be inert m hprd metab- 
olism [6]. 
In the present report we provrde evrdence that 
some commercially available ‘fatty acid poor’ or ‘fatty 
acid free’ albumms both of human and bovine orrgm 
contam apohpoprotem A-I (apo A-I) m appreciable 
amounts. Apo A-I has been shown to bmd avidly 
phosphohpids and produce drscordal particles [7], 
to bind easily to studied lipoproteins [8] and to be 
the specific cofactor for one of the key enzymes m 
lipoprotem metabolism, lecithin : cholesterol acyl 
transferase (LCAT, EC 2 3 1.43) [9]. Therefore, the 
use of such albumrn preparations m the study of 
hpoprotems may interfere with the mterpretatton of 
such experiments. We wish to caution against the use 
of commercral albumins m hpoprotem metabolism 
studies prior to quantifying apo A-I m them 
* Since there may be differences m results obtamed with 
various batches, we prefer not to ldentlfy the companies. 
Therefore, the various albumins are designated arbitrardy A 
to G and are ldentlfied by then lot no 
2. Materials and methods 
Albumms were purchased from Sigma Chemtcal Co. 
(St Louts, MO), Pentex, Mrles Labs (Kankakee, IL) and 
Armour Pharmaceutrcal Co (Chicago, IL). Bovine 
albumins*. A, fatty acid free (lot no. 22), B, fatty acid 
poor (lot no. 28), C, fatty acid free (lot no. 7442), 
D, crystallized (lot no. 8020), E, fraction V (lot no. 
47909). Human albumins F, fraction V (lot no. 134), 
G, fraction V (lot no. 8071) 
Human apohpoprotem A-I was purrfted and mono- 
specrfrc antrbodres to apo A-I were rarsed m rabbits as 
detailed m [lo]. Bovme apo A-I was isolated from 
dehprdated bovrne high densrty hpoprotems (HDL) 
d = 1.085-l 21 g/ml, by gel permeatron chromatog- 
raphy as m [ 111. Its purity was checked by poly- 
acrylamide gel electrophoresrs, double rmmunodtffu- 
sron and rmmunoelectrophoresrs [lo]. Antrbodres to 
bovme apo A-I were raised m rabbits according to the 
method described for human apo A-I [lo]. These 
antibodies were shown to be monospecrfrc, by double 
rmmunodrffusron and rmmunoelectrophoresrs as 
detailed m [lo] . 
Analytical methods protein was determmed by 
the Lowry method [ 121 using bovme serum albumin 
as the standard. Human apo A-I was quantified by 
double antibody radioimmunoassay [lo]. Bovme 
apo A-I was quantified by radial rmmunodrffusron m 
1% agarose gel, 0.05 M barbital buffer (pH 8 2) con- 
tammg 5% antrbovme apo A-I serum, according to 
the method for human apo A-I [ 131. The assay was 
shown to be specific, reacting only with bovme 
apo A-I and not wrth bovme albumm or globulins 
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The assay was ccurate m quantrfying apo A-I m 
bovine-HDL when compared to the results obtained 
by gel permeation chromatpgraphy [ IO,1 11. The 
sensitivity of the assay was 20 I.cglml with a coefficient 
of variation of 8%. Sodium dodecyl sulfate polyacryl- 
amide gel electrophoresrs (SDS-PAGE) was by the 
method m [ 14 ] adapted from [ 151. Phosphohpid 
content was determined according to [ 161. 
Various albumins, 300 mg, were mcubated with 
10 I.~M single lamellar vesicles of lecithin (prepared 
by Dr Y. Barenholz from egg yolk phosphatidyl- 
cholme (Maker Co., Jerusalem) by the method m 
[ 171) m 6 ml 0.15 M NaCl containing 0.05 M Tris- 
HCl (pH 7.5) for 2 h at 23°C. At the end of the lncuba- 
tion the density was raised to 1.2 1 g/ml with solid 
KBr and centrifuged, using a 40.3 rotor in a Beckman 
L3-50 ultracentrrfuge for 48 h 38 000 rev./mm and 
4°C. The tubes were sliced and the top 1.5 ml 
(d < 1.2 1 g/ml) was recentrifuged at the same density. 
The ultracentrifugally separated fractions were 
dialyzed for 48 h in 5 changes of 0.15 M NaCl con- 
taining 0.01% EDTA at 4°C. The incubation and 
ultracentrifugation procedures were repeated with the 
d > 1.2 1 g/ml fractions. 
3. Results and discussion 
Using the sensitive radrolmmunoassay techmque 
(10 ns/ml) we were able to detect and quantrfy 
human apo A-I directly in human albumins (table 1). 
With the radial immunodiffusion method for 
bovine apo A-I we could detect apo A-I m 
only one bovine albumin preparation (B). In order 
to overcome thrs low sensitivrty we have con- 
centrated apo A-I, taking advantage of the known 
Table 1 
Quanttflcation of apo A-I in commercially avarlable albumms (bovine and human) 
Albumms Apo A-I @g/g albumm)a Protem 
(mglg albumm) 
In commercral Ind < 121 Ind > 1.21 








Of 15 2 + 2.9 0 2.9 + 0.3 
197.0 i 25.3 172.8 f 135 0 5.1 f 0.4 
(16 7 + 2 3)e 
0 0 0 0.18 * 0.02 
0 0 0 0.21 * 0 03 
0 0 0 0.25 f 0.04 
Human 
F 3 2 f 0.5 2.7 f 0.5 
(0 3 f 0 05)e 0 0 16 f 0.02 
G 1.8 f 0.25 16 f 0.3 
(0.15 f 0.04)e 0 0.78 * 0.05 
a Bovme apo A-I content in bovme albumms (A-E) and human apo A-I in human 
albumins (F,G) 
b Assayed drrectly on solubrhzed orrgmal albumms (20% w/v) 
’ Quantriicatron of apo A-I or total protein on d < 1 21 g/ml fraction followmg incuba- 
tion with hposomes. The results are expressed per 1 g albumm subjected to mcubation 
d Apo A-I in d > 1.21 g/ml fractron followmg two incubations with lecithin hposomes 
e Results m parentheses express the additional apo A-I recovered m lecrthm vesrcles 
following a second incubation and centrrfugatron 
f Less than 100 pg bovine apo A-I per 1 g bovine albumm and < 50 ng human apo A-I 
per 1 g human albumin 
Results are mean * SD of 3 expermrents 
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Fig.1. SDS-PAGE of. (a) bovnm apo A-I (50 pg); (b) bovine 
albumin B (50 rg); (c) lrposomes mcubated with bovine 
albumm B (d < 1.21 g/ml) (50 Irg protem), (d) hpo- 
somes obtamed following a second mcubation with albumm B 
(25 pg). The gels were stained m 0.2% Coomassie blue Note 
the presence of a protem band in gels (c) and (d) with smular 
electrophoretic mobihty as bovine apo A-I (a). 
affinity of apo A-I for phospholipid liposomes [7]. 
Followmgincubation of the albumin preparations with 
egg yolk phosphatidylchol~e we have isolated the 
liposomes by floatation at d = 1.2 1 g/ml (table 1). 
Prior to the incubation with albumins, the liposomes 
were nonrea~~ve in both ~muno~ays. 
SDS-PAGE of these incubated hposomes 
(d < 1.2 1 g/ml) revealed the presence of a protem 
with rdentrcal mobility (molecular weight) as apo A-I 
of the corresponding species (f&.1). The same pattern 
as shown in fig.1 for bovme albumin B was also 
observed W&-I albumm A. Similar results were also 
obtained with human albumins (F and G) (not shown 
in fig-l). immunoassay of these liposomes enabled 
quantrfication of apo A-I in an additional commercial 
bovine albumin (A) (table 1). Repeating the incuba- 
tion and floatanon procedures enabled us to remove 
all the lmmunoassayable apo A-I from the human 
albumins (table 1). 
Apo A-I is a metabolically active apolipoprotein 
and participates in sever&teps m lipoprotein metab- 
olism. It binds phosphoBplds 171, removes cholesterol 
from cells in tissue culture, [18 ] and is a specific 
activator for LCAT [9]. Therefore, its introduction 
into m vitro systems in llpoproteln studies may inter- 
fere with the metabohc processes under investigation, 
Several available commercial albumins both of human 
and bovine origin, even m the ‘fatty acrd free’ forms, 
contain considerable amounts of this important apo- 
protem. Thus, we would like to caution against the 
use of these albumm preparations (especially m large 
quantities) without a prior check for the presence of 
apo A-I. In preliminary expenments rtseems that one 
can remove this apoprotem byabsorptron on phospha- 
trdylcholine vesicles. 
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